Fear, anxiety and embarrassment stop women going for breast screening

Researchers from the Gateshead Foundation Trust looked at why breast screening uptake varies between different areas covered by their screening programme.

They found that even in areas of high deprivation – a known reason for low breast screening uptake – GP practices’ screening rates still differed by over 10 per cent.

By speaking to women in focus groups they found that fear, anxiety and embarrassment were the main reasons women gave for not attending breast screening. The other reason given was denial of the disease, saying cancer would never happen to them.

Further work also showed women were not aware that breast cancer risk increases with age. And – worryingly – most women could only name two symptoms* of the disease.

Julie Tucker, lead author from the Gateshead Foundation Trust, said: “Our results show that more must be done to tackle the low uptake of screening and poor awareness of breast cancer symptoms. We must ensure that GPs, nurses and health professionals feel able to talk to women about the pros and cons of breast screening as well as what signs and symptoms they need to look out for.

“We also need to dispel some of the myths around breast cancer – it’s not a death sentence and more women are surviving this disease than ever before. This in turn will reduce women’s fear of the disease. The earlier breast cancer is diagnosed, the better the chance of survival so women shouldn’t be afraid of going to the doctor with symptoms or going for regular mammograms.”

Dr Jane Cope, director of the NCRI, said: “This is important research to help understand what is putting off some women going for breast screening. Every year over 48,000 women are diagnosed with breast cancer and around 12,000 die from the disease.”

More information: *Symptoms include a lump or thickening in an area of the breast; change in the size or shape of the breast; dimpling of the skin; a change in the shape of the nipple, particularly if it turns in, sinks into the breast or becomes irregular in shape; blood stained discharge from the nipple; a rash on the nipple or surrounding area; swelling or lump in the armpit.

Provided by Cancer Research UK